Enlicitide Decanoate is a medicine for adults with hypercholesterolemia, a condition where there is too much cholesterol (a type of fat) in the blood. This study is to see if the medicine works well and is safe over a longer time. The study is only for people who have already completed one of three earlier studies on this medicine. If you finished one of the earlier studies and did well, you might be able to join. You should not join if you had to stop taking the medicine before or if you had a serious problem from it. Also, you cannot join if you plan to start other medicines called PCSK9 inhibitors or if you are part of another study.

• The study will check long-term safety and effectiveness of the medicine.
• You must have completed one of the earlier studies with at least 80% compliance.
• You cannot join if you stopped the medicine before or are in another study.